Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematologic Malignancies
•
Medical Oncology
•
Myelodysplastic Syndromes
•
Hematology
Would you hold off iron chelation in a transfusion dependent MDS patient with elevated ferritin but with negative iron stain on the bone marrow?
Are there other investigations you would pursue to guide decision?
Related Questions
How do you approach severe anemia and thrombocytopenia in an elderly patient whose bone marrow biopsy shows hypercellular marrow with mild dysplasia in erythroid and megakaryocytic lineage but normal cytogenetics and a negative NGS panel?
How do you approach management for CCUS with severe cytopenias?
What is your approach for choosing between Imetelstat and Luspatercept in managing MDS related anemia?
How do you manage a patient with low risk MDS who achieves transfusion independence with luspatercept but continues to have fatigue?
What is your re-immunization strategy after auto SCT for patients with myeloma on dara/len maintenance?
Given the data from SWOG 1826 suggesting that Nivo-AVD is likely the preferred regimen for advanced Hodgkin lymphoma patients, are there scenarios where alternative regimens may still be preferred?
How do different inflammatory markers like CRP and ferritin contribute differently, if at all, to the monitoring of CART neurotoxicity?
In patients who relapse during a treatment-free period after achieving remission on prior 1st/2nd generation TKI, what factors should be taken into consideration when restarting treatment?
Does ASC4FIRST data justify the use of first-line Asciminib for all newly diagnosed CML over other TKIs, considering that the MMR difference was not significantly different, and post-progression survival data is not yet mature?
How do you time CSF analysis for suspected CNS lymphoma in patients who are on steroids?